Towards elimination of dog-mediated human rabies: experiences from implementing a large-scale demonstration project in Southern Tanzania by Mpolya, Emmanuel Abraham et al.
March 2017 | Volume 4 | Article 211
Original research
published: 06 March 2017
doi: 10.3389/fvets.2017.00021
Frontiers in Veterinary Science | www.frontiersin.org
Edited by: 
Salome Dürr, 
University of Bern, Switzerland
Reviewed by: 
Andre Coetzer, 
University of Pretoria, South Africa 
Darryn Knobel, 
Ross University School of Veterinary 
Medicine, Saint Kitts and Nevis
*Correspondence:
Emmanuel Abraham Mpolya 
emmanuel.mpolya@nm-aist.ac.tz
Specialty section: 
This article was submitted to 
Veterinary Epidemiology and 
Economics, 
a section of the journal 
Frontiers in Veterinary Science
Received: 30 September 2016
Accepted: 08 February 2017
Published: 06 March 2017
Citation: 
Mpolya EA, Lembo T, Lushasi K, 
Mancy R, Mbunda EM, Makungu S, 
Maziku M, Sikana L, Jaswant G, 
Townsend S, Meslin F-X, Abela-
Ridder B, Ngeleja C, Changalucha J, 
Mtema Z, Sambo M, Mchau G, 
Rysava K, Nanai A, Kazwala R, 
Cleaveland S and Hampson K (2017) 
Toward Elimination of Dog-Mediated 
Human Rabies: Experiences from 
Implementing a Large-scale 
Demonstration Project in Southern 
Tanzania. 
Front. Vet. Sci. 4:21. 
doi: 10.3389/fvets.2017.00021
Toward elimination of Dog-Mediated 
human rabies: experiences from 
implementing a large-scale 
Demonstration Project in southern 
Tanzania
Emmanuel Abraham Mpolya1,2,3*, Tiziana Lembo2, Kennedy Lushasi2,4, Rebecca Mancy2, 
Eberhard M. Mbunda5, Selemani Makungu5, Matthew Maziku5, Lwitiko Sikana4, 
Gurdeep Jaswant6, Sunny Townsend2, François-Xavier Meslin7, Bernadette Abela-Ridder8, 
Chanasa Ngeleja9, Joel Changalucha2,4, Zacharia Mtema4, Maganga Sambo2,4, 
Geofrey Mchau10, Kristyna Rysava2, Alphoncina Nanai11, Rudovick Kazwala6, 
Sarah Cleaveland2 and Katie Hampson2
1 Global Health and Biomedical Sciences, School of Life Sciences and Bioengineering, Nelson Mandela African Institution of 
Science and Technology, Arusha, Tanzania, 2 Institute of Biodiversity, Animal Health and Comparative Medicine, University of 
Glasgow, Glasgow, UK, 3 Paul G. Allen School for Global Animal Health, Washington State University, Pullman, WA, USA, 
4 Ifakara Health Institute, Dar es Salaam, Tanzania, 5 Department of Epidemiology, Ministry of Agriculture, Livestock and 
Fisheries, Dar es Salaam, Tanzania, 6 Preventive Veterinary Medicine, Sokoine University of Agriculture (SUA), Morogoro, 
Tanzania, 7 Food Safety Zoonoses and Food-Borne Diseases, World Health Organization (former WO staff), Geneva, 
Switzerland, 8 Neglected Zoonotic Diseases, WHO, Geneva, Switzerland, 9 Tanzania Veterinary Laboratory Agency (TVLA), 
Ministry of Agriculture, Livestock and Fisheries, Dar es Salaam, Tanzania, 10 Department of Epidemiology, Ministry of Health, 
Community Development, Gender, Elderly and Children (MoHCDGEC), Dar es Salaam, Tanzania, 11 Department of Neglected 
Tropical Diseases, World Health Organization – Country Office of Tanzania, Dar es Salaam, Tanzania
A Rabies Elimination Demonstration Project was implemented in Tanzania from 2010 
through to 2015, bringing together government ministries from the health and veter-
inary sectors, the World Health Organization, and national and international research 
institutions. Detailed data on mass dog vaccination campaigns, bite exposures, use of 
post-exposure prophylaxis (PEP), and human rabies deaths were collected throughout 
the project duration and project areas. Despite no previous experience in dog vaccination 
within the project areas, district veterinary officers were able to implement district-wide 
vaccination campaigns that, for most part, progressively increased the numbers of 
dogs vaccinated with each phase of the project. Bite exposures declined, particularly 
in the southernmost districts with the smallest dog populations, and health workers 
successfully transitioned from primarily intramuscular administration of PEP to intrader-
mal administration, resulting in major cost savings. However, even with improved PEP 
provision, vaccine shortages still occurred in some districts. In laboratory diagnosis, there 
were several logistical challenges in sample handling and submission but compared to 
the situation before the project started, there was a moderate increase in the number of 
laboratory samples submitted and tested for rabies in the project areas with a decrease 
in the proportion of rabies-positive samples over time. The project had a major impact 
on public health policy and practice with the formation of a One Health Coordination 
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BacKgrOUnD
Rabies is one of the oldest known zoonosis, which is defined as 
an acute progressive encephalitis that almost inevitably results in 
death without timely intervention (1). Rabies can be transmitted 
by several hosts, but domestic dogs are the main species that 
transmit the disease to humans (2). With a growing recognition 
of the need for One Health approaches to tackle zoonotic diseases 
(3), it has been recognized that a paradigm shift is required to 
tackle human rabies in low- and middle-income countries 
(LMICs), by focusing on immunization of the primary reservoir 
hosts, the domestic dogs.
In terms of the disease burden, rabies is responsible for an 
estimated 59,000 human deaths globally, about 96.0% of which 
occur in Africa and Asia (4). Particularly, Asia contributes 59.6% 
of annual deaths due to rabies, while Africa contributes 36.4% of 
annual deaths (4). The escalation of dog rabies across much of 
Asia and Africa is mainly due to the low priority given to control 
of the disease. This low priority is in turn due to a lack of aware-
ness of the true scale and magnitude of the disease burden as 
well as misperceptions as to the feasibility, cost-effectiveness, and 
public health benefits of dog rabies control (5, 6).
Since most LMICs still focus on post-exposure prophylaxis 
(PEP) as the only means to prevent human deaths from rabies 
(4), there is a clear need for greater focus on dog vaccination as 
a more sustainable and cost-effective way of addressing rabies 
in humans (7–9). Within this context, a demonstration project 
in Tanzania was initiated to prevent human rabies through the 
control and eventual elimination of canine rabies while improv-
ing the delivery of PEP to exposed patients, as well as surveillance 
and diagnostics. Finally, the project aimed to build a strategy to 
ensure sustainability of the rabies-free status beyond the project 
duration as illustrated in the Stepwise Approach towards Rabies 
Elimination—SARE (10).
Critical milestones of the project were therefore the progres-
sive reduction and eventual elimination of human deaths due 
to dog rabies together with decreased numbers of PEP doses 
delivered. These should be concomitant with a reduction of dog 
rabies cases and/or positivity rate of dog samples tested in the 
laboratory, coupled with increasing immunization coverage in 
the dog population and evidence of rabies-free status. In light of 
these milestones, we present our experiences of implementing 
this large-scale rabies control project.
MeThODOlOgY
Project areas
The project site in Tanzania included the mainland regions of 
Dar es Salaam, Lindi, Mtwara, Morogoro, and Pwani, as well as 
Pemba Island. This covered a total of 28 districts including 4 from 
Pemba, and 459 wards, as of the year 2010, with more than 8 
million inhabitants. Initially, the area was estimated to have about 
400,000 dogs, based on dog-to-human ratios generated from 
other areas of Tanzania extrapolated to the districts in Southern 
Tanzania with similar population characteristics (11). Through 
household and post-vaccination surveys, the actual number of 
dogs was subsequently determined to be between 100,000 and 
150,000 with much more variable human-to-dog ratios within 
districts.
The area of implementation was selected to exploit natural 
boundaries to facilitate the establishment and maintenance of a 
rabies-free area, including the coastline to the east, Udzungwa 
Mountains to the northwest, and Ruvuma River to the south. 
The Dar es Salaam–Mbeya highway to Morogoro and railway 
line to Kilosa defined the northern boundary of the project zone 
(Figure 1).
Project Management
The project was implemented collaboratively and primarily by 
bodies relevant to the animal and human health sectors with 
other sectors having a secondary role. The project organizational 
structure involved a national coordinator based at the World 
Health Organization (WHO)—Country Office of Tanzania. 
The National Coordinator worked with a multisector steering 
advisory committee, which consisted of representatives from key 
Tanzanian ministries dealing with livestock and human health 
through their focal persons, the WHO, the Sokoine University 
of Agriculture (SUA), and the University of Glasgow. Two 
laboratories dealt with diagnostic tasks: the Tanzania Veterinary 
Laboratory Agency (TVLA) in Dar es Salaam and the Sokoine 
Unit at the Prime Minister’s Office and development of the Tanzania National Rabies 
Control Strategy, which lays a roadmap for elimination of rabies in Tanzania by 2030 by 
following the Stepwise Approach towards Rabies Elimination (SARE). Overall, the project 
generated many important lessons relevant to rabies prevention and control in particular 
and disease surveillance in general. Lessons include the need for (1) a specific unit in 
the government for managing disease surveillance; (2) application of innovative data 
collection and management approaches such as the use of mobile phones; (3) close 
cooperation and effective communication among all key sectors and stakeholders; and 
(4) flexible and adaptive programs that can incorporate new information to improve their 
delivery, and overcome challenges of logistics and procurement.
Keywords: rabies elimination Demonstration Project, mass dog vaccination, southeastern Tanzania, One health, 
sare
FigUre 1 | Project area consisting of 28 districts from mainland Tanzania and Pemba island. Districts within the project area are demarcated in black with 
natural boundaries highlighted including the highway and railway in the north, the coastline in the east, mountains to the west, and the Ruvuma River in the south. 
The Selous Game Reserve is shaded in gray.
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University of Agriculture’s (SUA) Faculty of Veterinary Medicine 
Laboratory in Morogoro.
Project launch and implementation
The project was internationally launched in 2009 when there 
was no large-scale rabies control program in Tanzania. In 
2010, the project was initiated officially in Tanzania. Between 
2009 and 2010, the necessary human and material resources 
for the project were set up, including infrastructure for 
implementation and working relationships between relevant 
sectors. With the aim to revaccinate each district annually, 
training sessions were delivered to district veterinary officers, 
district medical officers, health workers, and laboratory staff. 
In addition, standard operating procedures were established 
for control, prevention, and surveillance activities. Health 
information relevant to rabies was continuously delivered to 
community leaders, students, teachers, and the general public 
throughout the project.
FigUre 2 | numbers of dogs vaccinated by month during each year 
of the project.
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Mass dog vaccination campaigns were conducted in phases, 
according to logistic constraints. Initially, the vaccination project 
focused on urban areas and then expanded to the entire project 
area, aiming to revaccinate each district annually. Household 
surveys and post-vaccination transects were used at different 
times during the project to estimate dog populations and vac-
cination coverage. Training and materials for sample collection 
and for diagnostic capacity were also provided by the project to 
district veterinary officers and livestock field officers. Fluorescent 
microscopes at the two laboratories were also refurbished with 
the support of the US Centers for Disease Control.
Under current national policy in Tanzania, PEP is distributed 
only to district hospitals. However, for this project, decentral-
ized provision of PEP was established through training of staff 
and distribution of vaccines to four additional health facilities 
in each district. Health-care workers were trained in the more 
immunogenic and cost-effective intradermal (ID) administration 
of vaccine to animal bite victims (12) and in the use of human 
rabies immunoglobulins (RIG). PEP was provided free of charge 
to bite victims across the project areas.
Data collection
The Ministry of Health, Community Development, Gender, 
Elderly and Children (MoHCDGEC) routinely records animal 
bites and human rabies deaths throughout Tanzania and numbers 
of human vaccinations administered and distributed within each 
district. These data were initially compiled before the project 
began to assess vaccine needs. During the project, the Ministry 
of Agriculture, Livestock and Fisheries (MALF) collected data on 
dog vaccination, and estimated dog populations and vaccination 
administration costs (13).
From 2011 onward, a mobile phone-based surveillance system 
was established to collect more detailed information needed for 
evaluation of project progress (14). Phones were distributed to 
the four health facilities responsible for district-level provision of 
PEP and to the district livestock officers. Livestock field officers 
and health workers were trained on how to report using mobile 
phones, enabling more rapid collection of extensive data than 
routine paper-based approaches. Variables collected included 
animal bite patient records, human rabies deaths (based on clinical 
criteria), PEP doses (demand and shortages), animals vaccinated 
during village-level vaccination campaigns, and results from 
laboratory investigation of samples and rabies suspect cases for 
animals. Livestock field officers and health workers collected and 
submitted these data as events occurred (vaccination campaigns, 
suspect rabid animals identified, animal bite patients reported 
to clinics). Researchers from Ifakara Health Institute monitored 
these records and followed up with users if they identified gaps 
without any submissions or if they received calls on a helpline 
indicating that difficulties had been encountered. The mobile 
phone-based surveillance provided relevant government stake-
holders with more detailed accessible data for evaluation of the 
project.
The mobile phone-based system was also used to record the 
responses of a household survey conducted to assess initial vacci-
nation coverage achieved and to review dog population estimates. 
A minimum of 30 households were sampled per village within 6 
randomly selected villages for each district. Following campaigns 
conducted from 2013 onward, post-vaccination transects were 
completed by trained enumerators in each village. Transects 
were walked in every village on the day after the campaign in 
that village (~2 h duration) recording collared dogs (vaccinated) 
and dogs without collars (unvaccinated). Further details of these 
transects are provided in Sambo et al. (this issue).
In eight mainland districts in Southern Tanzania and on Pemba 
Island, contact tracing methods were followed to investigate 
declines in the numbers of bite patients. Contact tracing involved 
compiling bite records from mobile phone-based surveillance, 
and visiting households to interview bite patients and identify 
the status of the biting animal based on clinical criteria and 
circumstances of the bite. All subsequent and previous exposures 
and suspect rabies cases were also traced following established 
methods (15).
Here, we compile these data, describe progress, and discuss 
challenges and successes of the project, including lessons for 
scaling up large-scale rabies control and prevention activities 
elsewhere.
resUlTs
Mass Vaccination of Domestic Dogs
When the project was officially launched in Tanzania in 2010, 
mass dog vaccination campaigns were planned and delivered 
only in urban centers in Dar es Salaam and Morogoro as well 
as Ulanga and Kilombero districts where vaccination campaigns 
were ongoing in collaboration with the Ifakara Health Institute 
(Figures 2 and 3). However, operations were rapidly scaled up 
with mass vaccinations conducted across the rural areas of the 
project area in 2011. This was the first time that such large-scale 
mass dog vaccination campaigns had been conducted against 
rabies in Tanzania. The country in general, and project areas in 
particular, had no prior experiences with controlling rabies at this 
level or scale.
Relatively low numbers of dogs were vaccinated in some 
rural areas in the first phase of implementation and not all 
FigUre 4 | District-level inter-campaign intervals between mass dog 
vaccination campaigns. Campaigns were initially intended to occur in 
every district 12 months apart. However, the actual distribution of intervals 
between consecutive campaigns varied from 11 months to over 30 months 
for some intervals in districts which only completed three campaigns within 
the 60-month period of study (2011–2015).
FigUre 3 | Dogs vaccinated in each district by month during each year of the project.
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district-level campaigns included every village; therefore, gaps 
in coverage were evident. Transects conducted from 2013 
until 2015 indicated an average of 65% coverage in villages 
where campaigns were conducted (detailed analyses of these 
data are underway). Coverage was probably lower than this as 
transects tend to miss young puppies and campaigns were not 
completed in every village; however, given that substantially 
more dogs (and villages) were vaccinated than during the 
initial campaigns, this represented a major improvement in 
implementation.
Lessons learned in these early mass dog vaccination cam-
paigns were incorporated into subsequent campaigns leading 
to an increase in dogs vaccinated as time went on (Figure  2). 
However, probably the single largest challenge to implementation 
was ensuring procurement and distribution of dog rabies vaccine 
within government and international systems. The initial plan 
was that dog vaccinations be conducted in each district annually. 
In practice, procurement challenges led to vaccination campaigns 
being conducted in phases involving a subset of local government 
authorities (Figures 2 and 3) and sometimes with long intervals 
between campaigns (Figure 4).
Logistical challenges included personnel changes in the 
WHO country office (16) and changes in vaccination procure-
ment systems. A project officer was replaced, but recruitment 
was not immediate. With the absence of a project officer, several 
processes took longer to be implemented. Before the new 
procurement system, vaccines were procured internationally 
by the international project coordinator at the WHO head-
quarters, who then arranged shipment to the WHO country 
office in Tanzania. With the new system, all purchases related 
to government projects were required to go through a procure-
ment process involving several procedures such as competitive 
tendering, deliberations by the procurement teams and selection 
of the supplier. These procedures meant that the purchase of vac-
cines was no longer straightforward, which led to disruptions 
in the vaccination schedule of the project. Lengthy intervals 
between campaigns were not ideal (Figures 3 and 4) and likely 
reduced their effectiveness. Detailed analyses of these data are 
underway to assess the impacts of these vaccinations and how 
this was affected by the disrupted schedule. A study to estimate 
the cost-effectiveness of the program in Tanzania found that the 
cost-per-dog vaccinated ranged from USD 2.5 to 22.49 across 
districts and phases with the average cost per phase falling from 
USD 11.27 in the first phase to USD 7.3 in the third phase (13). 
In comparison to other rabies elimination demonstration sites of 
KwaZulu-Natal and Cebu in the Philippines (17, 18), Tanzania 
had the highest cost-per-dog vaccinated mainly because of the 
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FigUre 6 | Transition from intramuscular (iM) to intradermal (iD) 
administration of post-exposure prophylaxis following training of 
health workers in 2010.
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FigUre 5 | average bite incidence/100,000 persons per month in the 
project area across districts and interquartile range of district-level 
bite incidence.
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over purchase of the vaccine in the early phases of the program 
and purchasing equipment for a program starting from scratch.
suspected rabies incidence, Bite 
exposures, PeP Use, and human rabies 
Deaths
From January 2011 until December 2015, there were over 23,800 
patient visits to clinics in the project area due to animal bites, with 
corresponding use of 22,295 doses of PEP. The age distribution 
of reported bite patients was consistent with previous findings 
from Tanzania and elsewhere, with younger people bitten more 
than adults (19–21). Overall, 45% of the bitten population was 
aged between 0 and 15 years of age, while over 50% of the bitten 
population was less than 20 years old.
The number of reported bite patients increased from 2011 
to 2012 from just over 1,600 bite patients to more than 2,700 
(Figure 5). From 2012 onward, bites declined, but fluctuations 
occurred particularly in 2014. When the project started in 2010, 
PEP was being administered solely through the intramuscular 
(IM) route, which has a maximum of five doses. However, follow-
ing training of health workers, a rapid shift of delivery from IM 
to ID—which has a maximum of four doses—was observed. The 
average number of PEP doses received per bite patient was 2.4. The 
overall reduction in bite patients led to markedly less use of PEP. 
The concurrent transition to ID administration (Figure 6) means 
that less vaccine was needed for the same number compared to 
IM administration. The main issue encountered during the 
transition related to procurement and distribution of appropri-
ate syringes. However, even with the shift to ID administration, 
shortages of PEP occurred, with Ulanga and Kilombero districts 
in Morogoro region the worst affected. Although training in RIG 
and its supply from external sources were also provided, RIG was 
used only infrequently (<1.5% of patients) due to scarcity, and 
most patients given RIG were treated between 2011 and 2013.
The areas with the largest dog populations (Morogoro region 
in central Tanzania) had the highest bite incidence and demand 
for PEP, whereas the most notable declines in bites were observed 
in the most southerly districts in Lindi and Mtwara regions 
(Figure  7). A cost-effectiveness study estimated that the cost 
per human PEP administered was approximately $22.41, while 
the cost per life saved ranged on average from $862 to $7,859 
(13). Detailed contact tracing of suspect rabies cases from bite 
patient records indicated that rabies was locally eliminated on 
Pemba island, falling from 42 suspect animal rabies cases based 
on clinical criteria before vaccination campaigns in 2011 to just 
2 in 2014 (Figure 8). No suspect rabies cases were identified on 
Pemba since May 2014 despite follow-up of all bite patients, until 
a recent incursion was detected in August 2016. Contact tracing 
in the southernmost districts of Tanzania also indicated major 
declines in suspect rabies cases.
Prior to the demonstration project, very little data on human 
deaths due to rabies were available. With the project implementa-
tion, more systematic follow-up of suspected human rabies cases 
was practiced throughout the project areas; however, none were 
laboratory confirmed. In 2010, 17 deaths due to rabies were 
recorded in the project areas. In the following year of 2011, there 
were 11 recorded deaths, which further declined to 3 in 2012. 
There were no suspect rabies deaths recorded in 2013. However, 
in years 2014 and 2015, the number spiked to 4 suspect rabies 
deaths for both years and just 2 in 2016. This decline was likely 
due to mass dog vaccinations reducing incidence in dogs, while 
awareness campaigns encouraged increased health seeking by 
dog bite victims and PEP accessibility improved. Among the 
recorded human rabies deaths, some bite victims did not seek 
treatment until symptom onset, whereas others sought care, but 
were unable to obtain vaccines.
Despite the training and materials for sample collection and 
diagnosis provided by the project, relatively few samples were 
submitted for testing. Local livestock officers reported consider-
able logistical difficulties in sample collection, including lack of 
resources and materials. Logistical disruptions to the project were 
known to have influenced sample collection during 2012 and 
2013. However, despite these challenges and in comparison to the 
situation before the project started, more samples were collected 
and analyzed during the course of this project. Almost 98% of 
samples collected—submitted as heads of dead animals—came 
from domestic dogs, with the remaining 2% from cats, cows, 
FigUre 7 | spatial distribution of average annual bite incidence/100,000 persons in districts in southern Tanzania. White zones correspond to national 
parks.
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goats, hyenas, jackals, and mongoose. The total number of sam-
ples per year showed an increasing trend with a few disruptions; 
there were a total of 22 samples in 2010, 40 samples in 2011, 60 
samples in 2012, 22 samples in 2013, 150 samples in 2014, and 140 
samples in 2015, making an average of 72 samples per year. About 
a quarter of all samples were diagnosed at the SUA laboratory, 
while three-quarters were diagnosed at the TVLA laboratory. 
While the number of samples submitted for diagnosis increased 
over the project duration, the proportion of rabies-positive sam-
ples decreased over time (Figure 9). Further analysis is underway 
to determine whether this fall in the number of rabies-positive 
samples was a direct effect of mass dog vaccination campaigns.
impacts on Policy
The Rabies Elimination Demonstration Project in Tanzania 
brought about major changes in policy. The heightened aware-
ness of rabies among policy makers led to the establishment of 
offices as well as guidelines focusing on rabies elimination. For 
the first time, a One Health Coordination Unit was formed in 
the Prime Minister’s Office to coordinate health interventions 
of diseases and conditions whose management requires a mul-
tisectoral approach, such as rabies. In addition, a multisectoral 
body of experts coming from universities, ministries, research 
institutions, and the private sector finalized a National Rabies 
Control Strategy which envisions elimination of rabies in both 
humans and dogs in Tanzania by 2030 and takes many lessons 
from this demonstration project (22). To achieve the vision of 
elimination of rabies in Tanzania by 2030, the National Rabies 
Control Strategy follows the Stepwise Approach towards Rabies 
Elimination (SARE) (10).
DiscUssiOn
Tanzania was among the three countries globally implementing 
the Rabies Elimination Demonstration Project through finan-
cial and technical assistance from the Bill and Melinda Gates 
Foundation (BMGF) and WHO. Activities were implemented 
through the MALF and the MoHCDGEC. The 5-year project 
FigUre 9 | Trends in the number of animal samples collected and 
analyzed between years 2010 and 2015. Before the project begun, only a 
handful of samples were collected and analyzed. That number rose steadily 
with the full installation of the project infrastructure, and in subsequent years, 
the proportion of rabies-positive samples showed a decline.
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FigUre 8 | suspect rabies cases in animals and human exposures on 
Pemba island by quarter (exposure, in the context of rabies, refers to 
being bitten by a possibly rabid dog).
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aimed at controlling and eliminating rabies in domestic dogs, 
thereby improving surveillance and diagnostics and providing 
targeted delivery of PEP to rabies-exposed patients. Five regions 
in Southern Tanzania including Pemba Island benefited from this 
project. Pemba Island was included for comparison of canine 
rabies elimination dynamics in island and inland settings.
The Rabies Elimination Demonstration Project in Southern 
Tanzania has achieved major successes. Since the project incep-
tion, major declines in dog bites and suspect rabies cases have 
been observed, with a concomitant fall in the demand for PEP, 
and a shift to more cost-effective ID administration of PEP. 
However, rabies is yet to be eliminated entirely from the project 
area. Moreover, the project encountered many challenges, mainly 
logistical from which lessons must be learnt for the future suc-
cessful elimination of rabies from Tanzania and from across 
sub-Saharan Africa.
This was the first large-scale One Health project in the coun-
try, with major infrastructure and human resource challenges. 
These included unreliable estimates of the dog population 
needed to purchase vaccines and consumables, shortcom-
ings in governance capacity that hindered coordination and 
implementation between and within animal and human health 
agencies, and a lack of experience in planning and delivering 
dog vaccination campaigns and in routine data collection to 
monitor their implementation. Lack of experience was rapidly 
overcome as livestock field officers and health workers became 
familiar with project activities and were supported by follow-up 
provided through the surveillance system. However the struc-
tural hurdles, such as unresponsive and overly bureaucratic 
procurement and distribution systems, and a lack of intersec-
toral coordination mechanisms were more problematic. These 
must be critically addressed for the future success of One 
Health programs in sub-Saharan Africa.
Difficulties were encountered in ensuring that budgets 
assigned to districts were not diverted to other local compet-
ing priorities and therefore those activities were conducted as 
required and scheduled, given the decentralized government 
structure. This was most apparent in the timing of vaccination 
campaigns, which were not conducted annually as initially 
planned. Interruption in campaign implementation is a recur-
ring issue in LMICs, with problems encountered in the other 
project demonstration sites (23), but less than in Tanzania. An 
important question to address in future is therefore how such 
interruptions impact on progress toward rabies elimination and 
how these can be minimized.
Implications of overestimating the dog population in the 
project proposal were quite important, especially as Tanzania was 
allocated a large proportion of the total BMGF 5-year funding for 
rabies pilot projects. Its impact on the cost-effectiveness of the 
program is obvious considering that the actual dog population to 
be immunized was about a third of the initially estimated target 
population size. As a consequence, larger than needed quantities 
of dog vaccines were procured and stored for long periods of 
time. Moreover, funds for dog vaccination campaigns were kept 
unused with the possibility of being reallocated to more press-
ing activities, though for a large part excess dog vaccines (and 
budget) were available for future years. Subsequent vaccination 
campaigns and post-vaccination monitoring enabled assessment 
of coverage and informed future vaccine purchase (21). However, 
procurement obstacles for both vaccines and consumables were 
considerable. Partly, this was due to a lack of continuity in project 
leadership and shortcomings in organizational capacity (16). 
These challenges highlight the catalytic role that mechanisms 
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such as the OIE rabies vaccine bank can play in overcoming 
bureaucratic challenges such as the tendering process to ensure a 
reliable supply of low-cost, high-quality vaccines.
Similar arguments apply to the supply of lifesaving PEP, which 
could be transformed if rabies post-exposure vaccines were 
incorporated within the portfolio of vaccines supported by the 
GAVI, the Vaccine Alliance. ID administration of PEP is cheaper 
than IM (reducing costs by at least 60% due to savings in vaccine) 
and equally immunogenic (12, 24–27). The rapid transition to ID 
administration demonstrated that health workers were capable of 
implementing this more cost-effective vaccine-sparing approach. 
Provision of free PEP administered intradermally to bite victims 
attending local health facilities greatly improved the PEP access 
across project areas. Nonetheless, even with this improved provi-
sion, PEP shortages still occurred, even at district hospitals, and 
this continues to be a challenge across the country more generally. 
Improved approaches are therefore needed for the distribution of 
lifesaving human rabies vaccines, given the unpredictability of 
demand, potential for epidemics, and urgency with which they 
must be administered.
Critically, many lessons spanning management, logistics, 
organization, implementation, and technological areas were 
learned through this project, which should be applied to the 
roll out of rabies elimination programs elsewhere in Tanzania 
and sub-Saharan Africa. These include the need to have a dedi-
cated management unit with focused responsibilities to deal 
with rabies, for close cooperation of key sectors and stakehold-
ers involved, and for flexible and responsive procurement and 
distribution systems. The Tanzanian government recognized 
the need for intersectoral financing and coordinating mecha-
nisms and recently established the One Health Coordination 
Unit under the Prime Minister’s Office to deal with endemic 
and emerging epidemics (28). Major costs for implementing 
the program were attributed to per diem payments for livestock 
field officers conducting campaigns out of their offices (13). 
This has prompted investigations into more efficient delivery 
methods for mass dog vaccination campaigns. The use of 
innovative methods such as mobile phones to support com-
prehensive surveillance infrastructure with timely data collec-
tion also improved decision-making. Spatial visualization of 
surveillance data and feedback from frontline health workers 
and livestock field officers captured through the mobile phone-
based system were used to communicate to policy makers the 
role of local government and the differences in implementation 
and results across the project area (14).
Overall, it is clear that the program delivered valuable public 
health benefits, but it is also evident that if dog vaccinations 
are not continued these gains will be lost. The recent incursion 
on Pemba highlights this situation, where no vaccination cam-
paigns were conducted since early 2014. However, the improved 
surveillance resulted in early detection and prompted a strong 
outbreak response. Moreover, it appears as though there is now 
only limited circulation of rabies in the southernmost districts 
in Tanzania and that elimination across a wider region is within 
reach. The ultimate success of the project will be seen in whether 
the sustainability plan for continued mass dog vaccinations is 
achieved and whether this leads to rabies elimination across 
the project area and spurs progress toward the elimination of 
rabies nationally.
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